RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY. (2024). Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, 31(1), 394-406. https://jrdiabet.ro/index.php/RJDNMD/article/view/307